有机化学人才网 | 最新人才 | 最新职位 | 技术交易 | 药物合成 |
   
全站搜索: |
  您当前位置:网站首页 >> 药物合成路线图解
 

药物详细合成路线

Name Befloxatone;MD-370503
Chemical Name 5(R)-(Methoxymethyl)-3-[4-[4,4,4-trifluoro-3(R)-hydroxybutoxy]phenyl]oxazolidin-2-one
CAS 134564-82-2
Related CAS
Formula C15H18F3NO5
Structure
Formula Weight 349.30961
Stage II 期临床
Company Sanofi-synthélabo (Originator)
Activity/Mechanism Antidepressants, Mood Disorders, Treatment of, PSYCHOPHARMACOLOGIC DRUGS, Smoking Cessation, Aid to, TREATMENT OF POISONING, DRUG ABUSE & DEPENDENCY, Treatment of Substance Dependency, MAO-A Inhibitors
Syn. Route 3
Route 1
befloxatone is obtained by condensation of 1,1,1-trifluoro-4-(tosyloxy)-2(r)-butanol (i) with 3-(4-hydroxyphenyl)-5(r)-(methoxymethyl)oxazolidin-2-one (ii) by means of k2co3 in hot dmf.
List of intermediates No.
n-[3-(2-hydroxyethyl)-4-(hydroxymethyl)phenyl]-4-(trifluoromethyl)[1,1-biphenyl]-2-carboxamide (i)
2-[[(methylsulfonyl)oxy]methyl]-5-([[4-(trifluoromethyl)[1,1-biphenyl]-2-yl]carbonyl]amino)phenethyl methanesulfonate (ii)
Reference 1:
    castaner, j.; sorbera, l.a.; rabasseda, x.; befloxatone. drugs fut 1999, 24, 10, 1057.
Reference 2:
    koenig, j.-j.; schoofs, a.; jarreau, f.-x.; rovei, v. (laboratoires delalande); 3-aryl oxazolidinones, process for their preparation and their therapeutical use. ep 0424243; ep 0424244; ep 0428421; jp 1992502333; jp 1992502334; jp 1992502335; us 5036090; us 5036091; us 5171747; us 5196543; wo 9105775 .
Reference 3:
    jarreau, f.-x.; koenig, j.-j.; rovei, v. (laboratoires delalande); 3-aryl-oxazolidinone derivs., process for their preparation and their use in therapeutics. ep 0511031; fr 2675504; jp 1993112542; us 5264443 .

Route 2
1) synthesis of butanol (i):1a) the reduction of 4,4,4-trifluoro-2-oxobutyric acid ethyl ester (iii) with nabh4 in dichloromethane gives 4,4,4-trifluoro-2-hydroxybutyric acid ethyl ester (iv), which is hydrolyzed with naoh in ethanol, yielding the corresponding acid (v). the optical resolution of (v) with 1(s)-phenylethylamine in hot ethanol affords the 3(r)-hydroxy enantiomer (vi) (1,3), which is reduced with nabh4 and bf3 ethearate in thf to provide 4,4,4-trifluorobutane-1,3(r)-diol (vii). finally, this compound is monotosylated by means of tosyl chloride and dmap in pyridine to afford intermediate (i).1b) the digestion of 4,4,4-trifluoro-3-hydroxybutyric acid ethyl ester (iv) with novozym in a phosphate buffer gives the corresponding (r)-enantiomer (viii), which is reduced with nabh4 in ethanol, yielding 4,4,4-trifluorobutane-1,3(r)-diol (vii) (4). finally, this compound is monotosylated by means of tosyl chloride as before to give butanol (i).
List of intermediates No.
(2s,3s,4s,5r,6s)-4-azido-5-[((2s,3r,4r,5s,6r)-4,5-dihydroxy-6-(hydroxymethyl)-3-[[3-(trifluoromethyl)benzoyl]amino]tetrahydro-2h-pyran-2-yl)oxy]-3-methoxy-6-(phenylsulfanyl)tetrahydro-2h-pyran-2-carboxamide (iii)
n-[3-(2-hydroxyethyl)-4-(hydroxymethyl)phenyl]-4-(trifluoromethyl)[1,1-biphenyl]-2-carboxamide (i)
n-(2-aminoethyl)acetamide (iv)
n-[2-[2-(acetamido)ethyl]-1,2,3,4-tetrahydro-6-isoquinolinyl]-4-(trifluoromethyl)[1,1-biphenyl]-2-carboxamide (v)
n-[2-(2-aminoethyl)-1,2,3,4-tetrahydro-6-isoquinolinyl]-4-(trifluoromethyl)[1,1-biphenyl]-2-carboxamide (vi)
4-bromophenethylamine; 2-(4-bromophenyl)-1-ethanamine (vii)
4-bromophenethylformamide (viii)
Reference 1:
    castaner, j.; sorbera, l.a.; rabasseda, x.; befloxatone. drugs fut 1999, 24, 10, 1057.
Reference 2:
    koenig, j.-j.; schoofs, a.; jarreau, f.-x.; rovei, v. (laboratoires delalande); 3-aryl oxazolidinones, process for their preparation and their therapeutical use. ep 0424243; ep 0424244; ep 0428421; jp 1992502333; jp 1992502334; jp 1992502335; us 5036090; us 5036091; us 5171747; us 5196543; wo 9105775 .
Reference 3:
    jarreau, f.-x.; koenig, j.-j.; rovei, v. (laboratoires delalande); 3-aryl-oxazolidinone derivs., process for their preparation and their use in therapeutics. ep 0511031; fr 2675504; jp 1993112542; us 5264443 .

Route 3
2) synthesis of oxazolidinone (ii):2a) the reaction of 4-benzyloxyaniline (ix) with 1,4-dioxaspiro[4.5]decan-2(s)-ylmethyl methanesulfonate (x) by means of tea at 140 c gives 3-(4-benzyloxyphenylamino)propane-1,2(r)-diol (xi), which is cyclized with diethyl carbonate and sodium methoxide in refluxing toluene, yielding 3-(4-benzyloxyphenyl)-5(r)-(hydroxymethyl)oxazolidin-2-one (xii). the methylation of (xii) with dimethyl sulfate, naoh and tetrabutylammonium bisulfate in hot toluene/water affords the corresponding methoxymethyl derivative (xiii). finally, this compound is debenzylated by hydrogenation with h2 over pd/c in ethanol/dichloromethane to give oxazolidinone (ii).2b) the methylation of 4(s)-(hydroxymethyl)-2,2-dimethyl-1,3-dioxolane (xiv) with dimethyl sulfate and naoh gives 4(s)-(methoxymethyl)-2,2-dimethyl-1,3-dioxolane (xv), which is hydrolyzed with hot aqueous hcl to 3-methoxypropane-1,2(r)-diol (xvi). the cyclization of (xvi) with diethyl carbonate by means of nah affords 4(s)-(methoxymethyl)-1,3-dioxolan-2-one (xvii) (2, 5). the condensation of (xvii) with n-(4-benzyloxyphenyl)carbamic acid methyl ester (xviii) (obtained by reaction of 4-benzyloxyaniline (ix) with methyl chloroformate) by means of k2co3 at 160 c provides the protected oxazolidinone (xiii), which is finally debenzylated as before to give oxazolidinone (ii).
List of intermediates No.
diethyl n-(4-aminobenzoyl)glutamate; diethyl 2-[(4-aminobenzoyl)amino]pentanedioate (xiv)
6-(trifluoromethoxy)-1,3-benzothiazol-2-ylamine; 6-(trifluoromethoxy)-1,3-benzothiazol-2-amine (ix)
2-[[(methylsulfonyl)oxy]methyl]-5-([[4-(trifluoromethyl)[1,1-biphenyl]-2-yl]carbonyl]amino)phenethyl methanesulfonate (ii)
7-bromo-3,4-dihydroisoquinoline (x)
7-bromo-1,2,3,4-tetrahydroisoquinoline (xi)
7-bromo-6-nitro-1,2,3,4-tetrahydroisoquinoline (xiii)
tert-butyl 7-bromo-6-nitro-3,4-dihydro-2(1h)-isoquinolinecarboxylate (xv)
tert-butyl 6-amino-3,4-dihydro-2(1h)-isoquinolinecarboxylate (xvi)
tert-butyl 6-([[4-(trifluoromethyl)[1,1-biphenyl]-2-yl]carbonyl]amino)-3,4-dihydro-2(1h)-isoquinolinecarboxylate (xvii)
n-(1,2,3,4-tetrahydro-6-isoquinolinyl)-4-(trifluoromethyl)[1,1-biphenyl]-2-carboxamide (xviii)
1h-imidazole-2-carbaldehyde (xii)
Reference 1:
    castaner, j.; sorbera, l.a.; rabasseda, x.; befloxatone. drugs fut 1999, 24, 10, 1057.
Reference 2:
    koenig, j.-j.; schoofs, a.; jarreau, f.-x.; rovei, v. (laboratoires delalande); 3-aryl oxazolidinones, process for their preparation and their therapeutical use. ep 0424243; ep 0424244; ep 0428421; jp 1992502333; jp 1992502334; jp 1992502335; us 5036090; us 5036091; us 5171747; us 5196543; wo 9105775 .
Reference 3:
    jarreau, f.-x.; koenig, j.-j.; rovei, v. (laboratoires delalande); 3-aryl-oxazolidinone derivs., process for their preparation and their use in therapeutics. ep 0511031; fr 2675504; jp 1993112542; us 5264443 .

来源:药化网

作者:药化小编

摘要:本文合成路线介绍的是药物中文名贝氟沙通;英文名Befloxatone;MD-370503;CAS[134564-82-2]

 
推荐VIP企业
无锡景耀生物科技有限公司
杭州卢普生物科技有限公司
宁波赛伦化工有限公司
苏州昊赛生物科技有限公司
北京嘉盛扬医药科技有限公司
上海泽涵生物医药科技有限公司
河北固安三利化工公司
郑州凯普瑞生物技术有限公司
上海药谷药业有限公司
兰州康寓信生物科技有限公司
湖北朗昕生化药业有限公司
武汉福鑫化工有限公司
嘉兴市英南化工有限公司
苏州迪飞医药科技有限公司
北京富安凯科技有限公司
上海盛中医药化工有限公司
连云港天和化学有限公司
南京晨瑞医药科技有限公司
南京苏如化工有限公司
常州瑞盛化工有限公司
热门文章
华东地区邻苯市场行情上涨
华北地区醋酸价格
华北地区正丁醇市场行情
新型“超分子纳米囊”可减少农药
苯胺跌势难改
华东地区BDO市场僵持整理
诺普信等3家国内企业首登三氟苯
华东地区BDO市场持续僵持
华南地区苯酚市场窄幅上行
PTA止跌在眼前
华北苯酐市场行情
江苏地区顺酐市场行情整理
华东苯酐市场行情
山东地区三氯甲烷价格
山东地区辛醇市场行情
山东地区二氯甲烷市场价格动态
华东地区醋酸价格
河南地区醋酸价格
山东地区醋酸价格
浙江地区醋酸价格
 友情链接
有机化学人才网  
首页 | 广告服务 | 建站服务 | 关于我们 | 联系我们 | 版权声明